New research from Emory University reveals that even seemingly small lifestyle improvements decreased one’s risk of developing heart disease, and these decreases also translate to lower risk of subsequent conditions, such as cancer, dementia, type 2 diabetes, and eye, liver, and kidney diseases. The study also links heart health to vision, hearing, and dental health. The study analyzed more than 450 peer-reviewed studies, assessing the overall impact of implementing the American Heart Association’s Life’s Simple 7™ metrics, a series of preventative measures, which include: not smoking, healthy eating, regular physical activity, maintaining a healthy weight, and managing blood pressure, cholesterol, and blood sugar.  Even a 1-point improvement on Life’s Simple 7™ scale, which ranges from 0-14 points, translates to critical health gains for the heart and other organs. 

The tumor microenvironment (TME) is a critical factor in antitumor immunity and treatment outcome in cancer therapy. We have developed an analysis tool called the immuno-oncology biological research (IOBR) to investigate the TME and its role in antitumor immunity. Leveraging multi-omics data, IOBR facilitates comprehensive analysis of TME characteristics, immune interactions, and their impact on immunotherapy outcomes.

A new study introduces an AI-integrated dynamic biomarker system that detects early disease tipping points and classifies thyroid cancer into actionable subtypes, paving the way for precision diagnosis and treatment.

This comprehensive review highlights the compositional and functional heterogeneity of intratumoral microbiota within the tumor microenvironment (TME), and their implications in tumorigenesis and cancer progression. The findings underscore the dual roles of these microbes in modulating immune responses and metabolic processes, offering new directions for cancer diagnostics and therapeutic interventions.